Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
CA |
|
I
|
ideaForge Technology Ltd
BSE:543932
|
IN |
|
PagerDuty Inc
NYSE:PD
|
US |
|
E
|
Endesa SA
XBER:ENA
|
ES |
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
Nike Inc
F:NKE
|
US |
Wall St Price Targets
AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for AUPH is 17.34 USD with a low forecast of 15.15 USD and a high forecast of 22.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AUPH's stock price target?
Price Target
17.34
USD
According to Wall Street analysts, the average 1-year price target for AUPH is 17.34 USD with a low forecast of 15.15 USD and a high forecast of 22.05 USD.
What is the Revenue forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Operating Income over the next 8 years is 24%.
What is the Net Income forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
6%
The compound annual growth rate for Net Income over the next 8 years is 6%.
